Profile
| Metric | Value |
|---|---|
| Full Name | Sionna Therapeutics, Inc. |
| Ticker | NASDAQ: SION |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | sionnatx.com |
| Employees | 48 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $43.21 | |
| Price, 1D Change | +16.09% | |
| Market Cap | $2B | |
| - | ||
| PE Ratio | - | |
| Beta | 0.80 | |
| Revenue | $0 | |
| Revenue, 1Y Change | 0.00% | |
| EPS | -$1.40 | |
| EPS, 1Y Change | -30.52% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | -$1.40 | |
| EPS Estimate | -$2.00 | |
| EPS Est. Change | -42.70% | |
| Revenue | $0.00 | |
| Revenue Estimate | - | |
| Revenue Est. Change | - | |
| Current Price | $43.21 | |
| Price Target | - | $47.50 |
| Price Tgt. Change | - | +9.93% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.00 | N/A | - | |
| -$2.16 | N/A | - |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | - | |
| Price, 3Y | - | |
| Market Cap, 1Y | - | |
| Market Cap, 3Y | - | |
| Revenue, 1Y | 0.00% | |
| Revenue, 3Y | 0.00% | |
| EPS, 1Y | -30.52% | |
| EPS, 3Y | -53.29% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $43.21 | |
| SMA 200 | $24.32 | |
| SMA 200 vs Price | -43.73% | |
| SMA 50 | $40.17 | |
| SMA 50 vs Price | -7.05% | |
| Beta | 0.80 | |
| ATR | $2.93 | |
| 14-Day RSI | 55.32 | |
| 10-Day Volatility | 106.24% | |
| 1-Year Volatility | 93.60% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| Dividends Paid | $0.00 | |
| Payout Ratio | 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $0.00 | |
| EPS | -$1.40 | |
| Gross Profit | -$668.00K | |
| - | ||
| Operating Profit | -$70.56M | |
| - | ||
| Net Income | -$61.69M | |
| - | ||
| EBITDA | -$69.89M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.06 | |
| Current Ratio | 14.49 | |
| Quick Ratio | 14.49 | |
| - | ||
| - | ||
| Altman Z-Score | 58.88 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | - | |
| PS Ratio | - | |
| PB Ratio | 6.00 | |
| EV/EBITDA | -20.37 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | -$163.71M | |
| Cash & Equivalents | $37.79M | |
| Total Assets | $185.75M | |
| Current Assets | $150.99M | |
| Total Liabilities | $19.10M | |
| Current Liabilities | $10.42M | |
| Total Debt | $9.75M | |
| Short Term Debt | $1.07M | |
| Accounts Payable | $1.19M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $70.56M | |
| Operating Expenses | $70.56M | |
| Cost Of Goods Sold | $668.00K | |
| SG&A | $13.27M | |
| D&A | $668.00K | |
| Interest Expense | $0.00 | |
| Income Tax | $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | -$52.79M | |
| CFI | -$126.91M | |
| CFF | $178.97M | |
| Capex | $27.00K | |
| Free Cash Flow | -$52.81M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| LifeSci Capital | ||
| RBC Capital | → | |
| BTIG | ||
| Freedom Capital Markets | ||
| Jones Trading | ||
| Raymond James | ||
| RBC Capital | ||
| Stifel |
Analyst sentiment
Institutional ownership
Screeners with SION
Data Sources & References
- SION Official Website www.sionnatx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/2036042/000162828025049251/0001628280-25-049251-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/2036042/000203604225000005/0002036042-25-000005-index.htm
- SION Profile on Yahoo Finance finance.yahoo.com/quote/SION
- SION Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/sion
FAQ
What is the ticker symbol for Sionna Therapeutics, Inc.?
The ticker symbol for Sionna Therapeutics, Inc. is NASDAQ:SION
Does Sionna Therapeutics, Inc. pay dividends?
No, Sionna Therapeutics, Inc. does not pay dividends
What sector is Sionna Therapeutics, Inc. in?
Sionna Therapeutics, Inc. is in the Healthcare sector
What industry is Sionna Therapeutics, Inc. in?
Sionna Therapeutics, Inc. is in the Biotechnology industry
What country is Sionna Therapeutics, Inc. based in?
Sionna Therapeutics, Inc. is headquartered in United States
When did Sionna Therapeutics, Inc. go public?
Sionna Therapeutics, Inc. initial public offering (IPO) was on February 7, 2025
Is Sionna Therapeutics, Inc. in the S&P 500?
No, Sionna Therapeutics, Inc. is not included in the S&P 500 index
Is Sionna Therapeutics, Inc. in the NASDAQ 100?
No, Sionna Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Sionna Therapeutics, Inc. in the Dow Jones?
No, Sionna Therapeutics, Inc. is not included in the Dow Jones index
When was Sionna Therapeutics, Inc. last earnings report?
Sionna Therapeutics, Inc.'s most recent earnings report was on November 5, 2025
When does Sionna Therapeutics, Inc. report earnings?
The next expected earnings date for Sionna Therapeutics, Inc. is March 19, 2026